446TiPREVEAL: A phase I/II, open-label, multicenter, dose escalation and dose expansion study of NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] with or without nivolumab (nivo) in patients (pts) with locally advanced or metastatic solid tumor malignancies
Saved in:
| Published in | Annals of oncology Vol. 29; no. suppl_8 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford University Press
01.10.2018
|
| Online Access | Get full text |
Cover
Loading…
| Author | Marcondes, M Rubas, W Zalevsky, J Tagliaferri, M A Hoch, U D'Angelo, S P Kivimae, S Conley, A P Borazanci, E Diab, A Zhang, J |
|---|---|
| Author_xml | – sequence: 1 givenname: A surname: Diab fullname: Diab, A organization: Department of Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA – sequence: 2 givenname: M surname: Marcondes fullname: Marcondes, M organization: Oncology Clinical Development, Nektar Therapeutics, San Francisco, CA, USA – sequence: 3 givenname: M A surname: Tagliaferri fullname: Tagliaferri, M A organization: Clinical Development, Nektar Therapeutics, San Francisco, CA, USA – sequence: 4 givenname: U surname: Hoch fullname: Hoch, U organization: Oncology, Nektar Therapeutics, San Francisco, CA, USA – sequence: 5 givenname: J surname: Zhang fullname: Zhang, J organization: Clinical Development, Nektar Therapeutics, San Francisco, CA, USA – sequence: 6 givenname: W surname: Rubas fullname: Rubas, W organization: Oncology, Nektar Therapeutics, San Francisco, CA, USA – sequence: 7 givenname: S surname: Kivimae fullname: Kivimae, S organization: Oncology, Nektar Therapeutics, San Francisco, CA, USA – sequence: 8 givenname: J surname: Zalevsky fullname: Zalevsky, J organization: Biology, Nektar Therapeutics, San Francisco, CA, USA – sequence: 9 givenname: A P surname: Conley fullname: Conley, A P organization: Department of Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA – sequence: 10 givenname: E surname: Borazanci fullname: Borazanci, E organization: Oncology, Honor Health/TGen, Scottsdale, AZ, USA – sequence: 11 givenname: S P surname: D'Angelo fullname: D'Angelo, S P organization: Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA |
| BookMark | eNqVkM1rwkAQxbfFQrUt9NrbHBUSs_kwmt7EWiqVUiT0IiWsyapbNrtLdqPNf99NFXruaYY3v3k8Xg91hBQUoQcfD32chB4RVsi9smiCcTKMwvASdf1RnLgTHPkd1MVJELrjURhdo57WXxjjOAmS7sV9FMUpe1_NP-bT5SNMQe2JprDwFgsHpKLC5WRDuQNlzQ3LqTC0cqCQlqE6J5wYJgUQUZy1b0WEbiVt6qIBuYW313TlBnEA63S5grE3AbKTgmnzCYrX-nz3I1jPnvwgcDfMBij-oCMze5DV75S1AcEOktcl2UC_XQfABCgbw0bT0FdGD04vXNp4vAFSHIjIraP1KKkh2lg4By05K8DUZSsTznbCUozqW3S1JVzTu_O8Qc7zPJ29uLJWmapYSaom83HWtp6dWs9OrWe29fCf-A9zJ49G |
| ContentType | Journal Article |
| Copyright | The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 |
| Copyright_xml | – notice: The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 |
| DOI | 10.1093/annonc/mdy279.433 |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19-23 October 2018, Munich, Germany |
| EISSN | 1569-8041 |
| ExternalDocumentID | 10.1093/annonc/mdy279.433 |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0SF 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6J9 70D AAEDW AAJKP AAJQQ AAKUH AALRI AAMVS AAOGV AAPNW AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABVKL ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTO ADBBV ADEYI ADHKW ADHZD ADJQC ADOCK ADRIX ADRTK ADVLN ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFETI AFIYH AFOFC AFXEN AGINJ AGKEF AGSYK AHMBA AHXPO AIAGR AIJHB AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AXUDD BAWUL BAYMD BHONS BTRTY BVRKM CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EJD F9B FDB GJXCC GX1 H13 H5~ HAR HW0 HZ~ I09 IH2 IOX J21 KAQDR KOM KOP KQ8 KSI KSN M-Z M41 M49 MHKGH N9A NCXOZ NGC NOYVH NU- O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX RW1 RXO TCURE TEORI TJX TR2 W8F WOQ X7H YAYTL YFH YKOAZ ZKX ~91 |
| ID | FETCH-oup_primary_10_1093_annonc_mdy279_4333 |
| ISSN | 0923-7534 |
| IngestDate | Wed Sep 11 04:52:36 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | suppl_8 |
| Language | English |
| License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-oup_primary_10_1093_annonc_mdy279_4333 |
| ParticipantIDs | oup_primary_10_1093_annonc_mdy279_433 |
| PublicationCentury | 2000 |
| PublicationDate | 20181001 |
| PublicationDateYYYYMMDD | 2018-10-01 |
| PublicationDate_xml | – month: 10 year: 2018 text: 20181001 day: 01 |
| PublicationDecade | 2010 |
| PublicationTitle | Annals of oncology |
| PublicationYear | 2018 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| SSID | ssj0006929 |
| Score | 4.633104 |
| SourceID | oup |
| SourceType | Publisher |
| Title | 446TiPREVEAL: A phase I/II, open-label, multicenter, dose escalation and dose expansion study of NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] with or without nivolumab (nivo) in patients (pts) with locally advanced or metastatic solid tumor malignancies |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb5tAEIC3SSpVvfRdNX1pDrWUCBMXsHn05sZpTRv3EJHKUhQhMOAg2WDZWGr66zuzA4ZUUeT2gtfrZYVnPvYxOzsrxAc6zEGPkkR1sHtWu5ZuqnaCA7nEnCQ93Uq0IKHNyaMf5vC8-23cG-_sDhpeS-siPJr8vnVfyf9oFfNQr7RL9h80u6kUMzCN-sUrahivW-kYJ1leijL8edI_5S3miyvslRQXq3Rdkh4djqWionktXnoPkjsm6ykiX_V4hVpiCsiGznm_sI0gMxpHn5VWhe_emaqbutLqffZOzxRagrWVYJpT5N1Wb6AsZutVWUrrUqnjgYYz0DDFB4qaBaXlN1_KT3KKzlLZQgYhDXbpCxkq6oiv0iq8IGcPh2-Vve_suvZewLrmcRHQ1qh0oqDE00gp1nPKxknGlM8fXjVH4XXU6Dyb3FhXIAehGxbeETYEeRZxY7qxUnnBdJYGCUW1lPl1-WHOZ2udN80pmr1xzCvu2qbZtJvqhopzPLaCxGWvYToqBXJqdiulIYdfnxUd0erbt_ZZHM8ryDL8y5iYR9e65Rx1OT7IX8HA7yy_K-5jyiDHxq_j2tHJdHSOOFk-eLW27xgdrqRTV8HbPBsjLO-JeFROjaDPnD8VO3H2TDwYlc4fz-89buL-CfogYQe347ptqEFvQwPzNhDQUEMOCHmZV0EOEnLIE6gghwtEHKyODSW3l0B4Q4U3XDThrgsRn5AvoUQbNmjDASUPIc2gwhoOEOpDvqVEGiqkqY4aaZBIg0Qamki_EO0vJ97xUEVh-gsOG-Ozu4fhs9B9FrqPQjdeij3Mil8JcDQnMSYUk1HTuviTEwZhz4xsU3ci-6Nl7YvWVlW-3rLcG_Gwfgneir1iuY7f4Si7CN9LiP4Ad67WGg |
| link.rule.ids | 315,783,787,27938,27939 |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=446TiPREVEAL%3A+A+phase+I%2FII%2C+open-label%2C+multicenter%2C+dose+escalation+and+dose+expansion+study+of+NKTR-262+%5BTLR+7%2F8+agonist%5D+plus+NKTR-214+%5BCD122-biased+agonist%5D+with+or+without+nivolumab+%28nivo%29+in+patients+%28pts%29+with+locally+advanced+or+metastatic+solid+tumor+malignancies&rft.jtitle=Annals+of+oncology&rft.au=Diab%2C+A&rft.au=Marcondes%2C+M&rft.au=Tagliaferri%2C+M+A&rft.au=Hoch%2C+U&rft.date=2018-10-01&rft.pub=Oxford+University+Press&rft.issn=0923-7534&rft.eissn=1569-8041&rft.volume=29&rft.issue=suppl_8&rft_id=info:doi/10.1093%2Fannonc%2Fmdy279.433&rft.externalDocID=10.1093%2Fannonc%2Fmdy279.433 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |